Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,067 | -16.8% | 18,361 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $120,237 | +35.4% | 17,708 | -0.1% | 0.00% | 0.0% |
| Q1 2023 | $88,777 | +4.8% | 17,720 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $84,746 | -66.2% | 17,366 | -0.4% | 0.00% | -50.0% |
| Q3 2022 | $251,000 | -3.5% | 17,430 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $260,000 | +26.2% | 17,184 | -1.0% | 0.00% | +100.0% |
| Q1 2022 | $206,000 | -31.6% | 17,350 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $301,000 | -44.9% | 18,572 | -2.9% | 0.00% | -33.3% |
| Q3 2021 | $546,000 | -17.5% | 19,128 | -2.3% | 0.00% | +50.0% |
| Q2 2021 | $662,000 | +23.0% | 19,582 | +10.1% | 0.00% | 0.0% |
| Q1 2021 | $538,000 | -38.7% | 17,783 | +0.3% | 0.00% | -33.3% |
| Q4 2020 | $878,000 | +27.8% | 17,736 | -0.9% | 0.00% | 0.0% |
| Q3 2020 | $687,000 | -13.1% | 17,905 | -2.2% | 0.00% | -25.0% |
| Q2 2020 | $791,000 | +116.7% | 18,311 | +30.8% | 0.00% | +100.0% |
| Q1 2020 | $365,000 | -21.2% | 13,995 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $463,000 | +38.2% | 14,805 | +15.2% | 0.00% | +100.0% |
| Q3 2019 | $335,000 | +13.2% | 12,850 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $296,000 | +155.2% | 12,939 | +191.4% | 0.00% | – |
| Q1 2019 | $116,000 | +24.7% | 4,441 | -3.1% | 0.00% | – |
| Q4 2018 | $93,000 | – | 4,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,194,278 | $108,639,000 | 6.47% |
| Memorial Sloan Kettering Cancer Center | 216,916 | $10,740,000 | 4.55% |
| Burrage Capital Management LLC | 114,962 | $5,692,000 | 4.34% |
| MPM BioImpact LLC | 674,582 | $33,398,000 | 2.88% |
| First Light Asset Management, LLC | 635,652 | $31,471,000 | 2.33% |
| Cormorant Asset Management, LP | 1,661,647 | $82,268,000 | 1.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 219,419 | $10,863,000 | 1.05% |
| ORACLE INVESTMENT MANAGEMENT INC | 126,342 | $6,255,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 131,016 | $6,487,000 | 0.58% |
| Artal Group S.A. | 285,028 | $14,112,000 | 0.30% |